EUVIMEDEUVIMED entdecken
Open Access

Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data

A E Roder, K E E Johnson iD, M Knoll, M Khalfan, B Wang, S Schultz-Cherry iD, S Banakis, A Kreitman, C Mederos, J-H Youn, R Mercado, W Wang und 9 weitere

mBio · 30.06.2023

DOI: 10.1128/mbio.01046-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, online erschienen am 30.06.2023. Verfasst von A E Roder und 20 weiteren Autor:innen. Beteiligte Einrichtung: Systems Genomics Section, Laboratory of Parasitic Diseases, DIR, NIAID, NIH , Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: COVID-19, Viruses, Orthomyxoviridae. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High error rates of viral RNA-dependent RNA polymerases lead to diverse intra-host viral populations during infection. Errors made during replication that are not strongly deleterious to the virus can lead to the generation of minority variants. However, accurate detection of minority variants in viral sequence data is complicated by errors introduced during sample preparation and data analysis. We used synthetic RNA controls and simulated data to test seven variant-calling tools across a range of allele frequencies and simulated coverages. We show that choice of variant caller and use of replicate sequencing have the most significant impact on single-nucleotide variant (SNV) discovery and demonstrate how both allele frequency and coverage thresholds impact both false discovery and false-negative rates. When replicates are not available, using a combination of multiple callers with more stringent cutoffs is recommended. We use these parameters to find minority variants in sequencing data from SARS-CoV-2 clinical specimens and provide guidance for studies of intra-host viral diversity using either single replicate data or data from technical replicates. Our study provides a framework for rigorous assessment of technical factors that impact SNV identification in viral samples and establishes heuristics that will inform and improve future studies of intra-host variation, viral diversity, and viral evolution. IMPORTANCE When viruses replicate inside a host cell, the virus replication machinery makes mistakes. Over time, these mistakes create mutations that result in a diverse population of viruses inside the host. Mutations that are neither lethal to the virus nor strongly beneficial can lead to minority variants that are minor members of the virus population. However, preparing samples for sequencing can also introduce errors that resemble minority variants, resulting in the inclusion of false-positive data if not filtered correctly. In this study, we aimed to determine the best methods for identification and quantification of these minority variants by testing the performance of seven commonly used variant-calling tools. We used simulated and synthetic data to test their performance against a true set of variants and then used these studies to inform variant identification in data from SARS-CoV-2 clinical specimens. Together, analyses of our data provide extensive guidance for future studies of viral diversity and evolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19VirusesOrthomyxoviridaeHumansSARS-CoV-2MutationHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

SARS-CoV-2bioinformaticsgenomicsinfluenza

Autor:innen und Institutionen

  • Systems Genomics Section, Laboratory of Parasitic Diseases, DIR, NIAID, NIH , Bethesda, Maryland, USA.
  • Department of Biology, Center for Genomics and Systems Biology, New York University , New York, New York, USA.
  • Department of Infectious Diseases, St Jude Children Research Hospital , Memphis, Tennessee, USA.
  • Department of Laboratory Medicine, NIH , Bethesda, Maryland, USA.
  • Institute for Biological Physics, University of Cologne , Cologne, Germany.
  • Department of Medicine, New York University Langone Vaccine Center , New York, New York, USA.

ORCID-Profile: K E E Johnson, S Schultz-Cherry, D Ruchnewitz, S Das, D Gresham, E Ghedin

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | National Institute of General Medical Sciences

Zitieren

APA

Roder, A. E., Johnson, K. E. E., Knoll, M., Khalfan, M., Wang, B., Schultz-Cherry, S., Banakis, S., Kreitman, A., Mederos, C., Youn, J. H., Mercado, R., Wang, W., Chung, M., Ruchnewitz, D., Samanovic, M. I., Mulligan, M. J., Lässig, M., Luksza, M., Das, S., …, & Ghedin, E. (2023). Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data. mBio. https://doi.org/10.1128/mbio.01046-23

Vancouver

Roder AE, Johnson KEE, Knoll M, Khalfan M, Wang B, Schultz-Cherry S, et al. Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data. mBio. 2023. doi:10.1128/mbio.01046-23

BibTeX
@article{Roder2023,
  author = {Roder, A E and Johnson, K E E and Knoll, M and Khalfan, M and Wang, B and Schultz-Cherry, S and Banakis, S and Kreitman, A and Mederos, C and Youn, J-H and Mercado, R and Wang, W and Chung, M and Ruchnewitz, D and Samanovic, M I and Mulligan, M J and Lässig, M and Luksza, M and Das, S and Gresham, D and Ghedin, E},
  title = {Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.01046-23}
}
Kostenlos starten →